Pharmacovigilance education to healthcare professionals: Will it affect their performance in reporting adverse drug reactions?

Aim To assess impact of pharmacovigilance (PV) educational program on knowledge, attitude and practice (KAP) of healthcare professionals (HCPs). Methods a prospective study was conducted on HCPs at an Egyptian hospital. The study included: pre‐education phase; where KAP questionnaire was administered by HCPs to obtain baseline data, intervention phase; where educational sessions were held by clinical pharmacists and Egyptian PV centre, and post‐education phase; where the questionnaire was re‐administered by participants 9 months post‐receiving educational sessions. The questionnaire comprised five sections: participants' demographics, knowledge, attitude and practice sections and two multiple choice questions asking about the importance of establishment of ADRs monitoring centre, and factors hindering ADRs reporting. Pre‐education and post‐education data were compared. Results From 221 HCPs invited to participate, only 153 filled the pre‐education and post‐education questionnaires. At baseline, the median (range) of the total KAP score were 1 (0‐7), 1 (0‐4) and 4 (0‐14) for physicians, nurses and pharmacists, respectively. All KAP scores were low for all HCPs at baseline with the pharmacists having significantly higher knowledge and attitude scores compared with physicians, and nurses (P